Accumulate Strides Pharma Science; target of Rs 731: Geojit
Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 731 in its research report dated December 26, 2023.
Source: moneycontrol.com
Page 5 - Strides Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Strides Pharma Today - Breaking & Trending Today
Strides Pharma stocks: Buy Strides Pharma Science, target price Rs 630: Prabhudas Lilladher
Promoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
Source: indiatimes.com
Strides Pharma receives FDA OK for 2 generics
Strides Pharma has received the FDA's clearance for generic Suprep Bowel Prep Kit Oral Solution and generic Keppra Oral Solution.
Source: drugstorenews.com
Strides Pharma rallies after seizure drug receives US FDA approval
The company's wholly owned step-down subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval.
Source: moneycontrol.com
Strides Pharma gains nearly 4% on USFDA approval for oral solution to treat seizures
Strides Pharma Share Price: trides Pharma Science Ltd's (Strides) step‐down wholly-owned subsidiary received the approval for Levetiracetam Oral Solution USP, 100 mg/mL. Strides Pharma said it would manufacture the product at its facility in Bengaluru.
Source: cnbctv18.com